PB
TARO

Pinnacle Bancorp’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Pinnacle Bancorp’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43
Closed -$1K – 769
2022
Q3 		$1K Hold
43
– – ﹤0.01% 737
2022
Q2 		$2K Hold
43
– – ﹤0.01% 736
2022
Q1 		$2K Hold
43
– – ﹤0.01% 732
2021
Q4 		$2K Hold
43
– – ﹤0.01% 702
2021
Q3 		$3K Hold
43
– – ﹤0.01% 696
2021
Q2 		$3K Hold
43
– – ﹤0.01% 693
2021
Q1 		$3K Buy
+43
New +$3.27K ﹤0.01% 694
2020
Q1 		– Sell
-37
Closed -$3K – 701
2019
Q4 		$3K Hold
37
– – ﹤0.01% 626
2019
Q3 		$3K Hold
37
– – ﹤0.01% 684
2019
Q2 		$3K Buy
+37
New +$3.66K ﹤0.01% 666

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Pinnacle Bancorp's TARO Position: Q4 2022 in Review

Pinnacle Bancorp sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2022, closing a stake of 43 shares — an estimated $1K sold.

Pinnacle Bancorp first reported a position in TARO in Q2 2019 and held it in 10 quarters. The position peaked at $3K in Q3 2021. 62 funds tracked by Wall St. Rank hold TARO as of Q4 2022.

  • Pinnacle Bancorp reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Bancorp sold 43 Taro Pharmaceutical Industries Ltd. shares in Q4 2022, an estimated $1K.
  • Pinnacle Bancorp first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2019 and held it in 10 quarters.
  • Pinnacle Bancorp's Taro Pharmaceutical Industries Ltd. position peaked at $3K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2022.

Based on Pinnacle Bancorp's 13F filing for Q4 2022, filed 24 Jan 2023.